Soy, red clover, and isoflavones and breast cancer: a systematic review.
- 2013-11-28
- Systematic Review · n = 131
- PloS one 8(11)
- Heidi Fritz
- Dugald Seely
- Gillian Flower
- Becky Skidmore
- Rochelle Fernandes
- Sarah Vadeboncoeur
- Deborah Kennedy
- Kieran Cooley
- Raimond Wong
- Stephen Sagar
- Elham Sabri
- Dean Fergusson
- PubMed: 24312387
- DOI: 10.1371/journal.pone.0081968
- High evidence
- Clinical
Soy consumption may be associated with reduced risk of breast cancer incidence, recurrence, and mortality.
- Effect
- Beneficial
- Effect size
- Large
- Significant
- Yes
- Dose
- 25-50 mg isoflavones (2-3 servings daily)